Gyre Therapeutics, Inc. GYRE Accounts Payable

Accounts Payable at other companies

Eli LillyLLY

$6.11B+50.0%

Madrigal Pharmaceuticals, Inc.MDGL

$34.51M-9.1%

Viking TherapeuticsVKTX

$67.18M+772%

Theravance BiopharmaTBPH

$652K-61.1%

Rigel PharmaceuticalsRIGL

$4.49M+13.5%

Zevra Therapeutics, Inc.ZVRA

$13.96M-11.9%

FAQ

What is Gyre Therapeutics, Inc.'s accounts payable?

Gyre Therapeutics, Inc. (GYRE) reported accounts payable of $1.24M in Q2 2026.

How has Gyre Therapeutics, Inc.'s accounts payable changed year-over-year?

Gyre Therapeutics, Inc.'s accounts payable increased by 1640.8% year-over-year, from $71K to $1.24M.

What is the long-term trend for Gyre Therapeutics, Inc.'s accounts payable?

Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s accounts payable has grown at a -25.8% compound annual growth rate (CAGR), from $5.93M to $1.34M.

What does accounts payable mean?

Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.